---
category: news
title: "BioXcel Therapeutics to Present at the 2021 Jefferies London Healthcare Conference"
excerpt: "BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a clinical-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology,"
publishedDateTime: 2021-11-11T12:25:00Z
originalUrl: "https://www.tmcnet.com/usubmit/-bioxcel-therapeutics-present-the-2021-jefferies-london-healthcare-/2021/11/11/9489984.htm"
webUrl: "https://www.tmcnet.com/usubmit/-bioxcel-therapeutics-present-the-2021-jefferies-london-healthcare-/2021/11/11/9489984.htm"
type: article
quality: 13
heat: 13
published: false

provider:
  name: TMCnet
  domain: tmcnet.com

topics:
  - AI in Healthcare
  - AI

related:
  - title: "BioXcel Therapeutics Reports Third Quarter 2021 Financial Results and Recent Operational Highlights"
    excerpt: "BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a clinical-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology,"
    publishedDateTime: 2021-11-10T12:04:00Z
    webUrl: "https://www.tmcnet.com/usubmit/-bioxcel-therapeutics-reports-third-quarter-2021-financial-results-/2021/11/10/9488656.htm"
    type: article
    provider:
      name: TMCnet
      domain: tmcnet.com
    quality: 0

secured: "RB2r8m/BJkjJtm/ESdNDIayEdByxQT842Oak4F33mSnKewEelhMDUGi2lfLXeWf0b1lnwkCUrfScSQqC12czMn8u0Gex3UZNMD/015TWRdxTOPlw59Cz/iZXEleBxmkmpJruV6Gpo3GSxGjNxnLNI5W0TBz7Dopi48/fUMcmjZZUerC5iaxQAl0wLfsjQ/bb7UIMdeU1APCg9o9QkdwzV6Y7Zo6ScZUWufRg+0sDzTi4pCGeL+2wvaIavQpjTJt1L/ihO9HxnOb7PwTefBI/dgE22wfnBYYkJrKxj63b1C1u0PI0Izh1iUxo/TLIMdaf0pfP2mKqqB8AHLRJvy5ikuT3niSCv5XEFrgEsCXTVOk=;s5mBLc9mf8rjJ3IEU2BtwA=="
---

